RPS6KB1 and ovarian carcinoma: In ovarian cancer cells, sepiapterin abrogated the increase in migration and proliferation triggered by vascular endothelial growth factor-A (VEGF-A) and p70S6K-dependent VEGRF2 expression in a NO-independent mechanism.